Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03780452 · ClinicalTrials.gov registry record
Compression Nail for Tibiocalcaneal Arthrodesis
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 13
- Enrollment target
NCT03780452: Completed study, sponsored by University of Alabama at Birmingham.
NCT03780452 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03780452 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the clinical efficacy of a novel dynamic compression intramedullary nail for tibiotalocalcaneal (TTC) arthrodesis
Primary Outcome
Visual Analog Scale (VAS). Patients will disclose their pain level using the Visual Analog Scale, which measures pain on a scale of 0 - 100, with 0 indicating no pain and 100 indicating severe pain.
Interventions
- DEVICE novel dynamic compression intramedullary nail
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2020-11-15 |
| Est. Completion | 2024-07-10 |
What the finished NCT03780452 record still lists
NCT03780452 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which novel dynamic compression intramedullary nail is the first listed.
NCT03780452 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03780452 about?
NCT03780452 is a clinical study titled "Compression Nail for Tibiocalcaneal Arthrodesis". The purpose of this study is to determine the clinical efficacy of a novel dynamic compression intramedullary nail for tibiotalocalcaneal (TTC) arthrodesis
What is the current status of trial NCT03780452?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2020-11-15. Estimated completion is 2024-07-10.
What interventions are being tested in trial NCT03780452?
The interventions under investigation include: novel dynamic compression intramedullary nail (DEVICE).
Who is sponsoring clinical trial NCT03780452?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI